Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
06/2000
06/06/2000US6071938 Benzopyrans
06/06/2000US6071937 Oxymethoxy-3-aryl-pyrone derivatives
06/06/2000US6071931 AT1 -receptor antagonists for preventing and treating postischemic renal failure and for protecting ischemic kidneys
06/06/2000US6071916 Sulfate salts having improved solubility in gastric acid solution resulting in greater oral absorption/bioavailability aids; arc(aids-related complex); containing benzofuran, piperazine, benzene and indane rings
06/06/2000US6071906 Inhibits or modulates the inducible isoform of nitric oxide synthase over the the constitutive isoforms; antiarthritic, -diabetic, ischemic, thrombosis agents; cardiovascular disorders; toxic shock syndrome; autoimmune diseases
06/06/2000US6071895 Polar-substituted hydrocarbons
06/06/2000US6071860 For selective control of broad-leaved and grass weeds in crops of useful plants
06/03/2000CA2291566A1 Catalysts for the enantioselective epoxidation of c=c double bonds
06/02/2000WO2000031211A1 Liquid crystal compound
06/02/2000WO2000031072A1 Process for making 5-substituted pyrazoles using dithietanes
06/02/2000WO2000031071A1 2-alkyl-5-halo-3-[2'-(tetrazol-5-yl)-biphenyl-4-ylmethyl]-3h-imidazole-4-carboxaldehyde acetal derivatives, their preparation and use
06/02/2000WO2000031070A1 Novel benzofurane derivatives, preparation method, use as medicines and pharmaceutical compositions containing same
06/02/2000WO2000031068A1 Polyhydroxylated heterocyclic derivatives as anti-coagulants
06/02/2000WO2000031067A1 Propanoic acid derivatives as integrin inhibitors
06/02/2000WO2000031063A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
06/02/2000WO2000031053A1 Il-5 inhibiting 6-azauracil derivatives
06/02/2000WO2000031051A1 Quinoline and quinoxaline compounds as pdgf-receptor and/or lck tyrosine kinase inhibitors
06/02/2000WO2000031050A1 Quinoline and quinoxaline compounds
06/02/2000WO2000031049A1 Quinoline and quinoxaline compounds as pdgf-r and/or lck tyrosine kinase inhibitors
06/02/2000WO2000031039A1 Substituted benzo[de]isoquinoline-1,3-diones
06/02/2000WO2000031032A1 Pyrrolidine derivatives-ccr-3 receptor antagonists
06/02/2000WO2000030640A1 Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia
06/02/2000CA2352584A1 Quinoline and quinoxaline compounds
06/02/2000CA2352583A1 Quinoline and quinoxaline compounds as pdgf-r and/or lck tyrosine kinase inhibitors
06/02/2000CA2352278A1 Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia
06/02/2000CA2352261A1 Quinoline and quinoxaline compounds as pdgf-receptor and/or lck tyrosine kinase inhibitors
06/02/2000CA2351725A1 Substituted pyrazoles as p38 kinase inhibitors
06/02/2000CA2351348A1 Substituted benzo[de]isoquinoline-1,3-diones
06/02/2000CA2350903A1 Pyrrolidine derivatives-ccr-3 receptor antagonists
06/02/2000CA2350081A1 Process for making 5-substituted pyrazoles using dithietanes
05/2000
05/31/2000EP1004593A2 Backbone modified oligonucleotide analogues
05/31/2000EP1004581A2 Process for the preparation of thalidomide
05/31/2000EP1004580A2 Imides as inhibitors of TNF alpha
05/31/2000EP1004572A2 Amines as inhibitors of TNF alpha
05/31/2000EP1003846A1 Protease inhibitors
05/31/2000EP1003741A1 Substituted herbicide tetrazolinonecarboxylic acid amides
05/31/2000EP1003740A2 Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagoists
05/31/2000EP1003737A1 Phenyl urea and phenyl thiourea derivatives as hfgan72 antagonists
05/31/2000EP1003736A1 Substituted 4-benzoyl-pyrazoles
05/31/2000EP1003723A1 2-acylaminopropanamines as tachykinin receptor antagonists
05/31/2000EP1003721A1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
05/31/2000EP1003541A1 Inhibitors of hiv reverse transcriptase
05/31/2000EP1003514A1 Cyclic amine modulators of chemokine receptor activity
05/31/2000EP1003504A2 Indole derivatives and their use as mcp-1 antagonists
05/31/2000EP0882016B1 Alkylated styrenes as prodrugs to cox-2 inhibitors
05/31/2000DE19955794A1 Pyrrolidin-Derivate-CCR-3-Rezeptor-Antagonisten Pyrrolidine derivatives-CCR-3 receptor antagonists
05/31/2000DE19955340A1 CCR-3-Rezeptor-Antagonisten CCR-3 receptor antagonists
05/31/2000CN1255162A Protease inhibitors
05/31/2000CN1255161A Protease inhibitors
05/31/2000CN1255126A Heterocyclically substituted aromatic amino compounds with herbicidal effect
05/31/2000CN1255124A Substituted isoquinoline derivatives and their use as anticonulsants
05/31/2000CN1255123A Process for covalently coupling organic compounds utilizing diboron derivatives
05/31/2000CN1255121A Selective epoxidation process for preparing pharmaceutical compounds
05/31/2000CN1255119A Protease inhibitors
05/30/2000US6069257 Process for the production of tetrazolylbenzopyrans
05/30/2000US6069254 Carboxamide derivatives of piperidine for the treatment of thrombosis disorders
05/30/2000US6069252 Hiv, hepatitus b virus and other viruses replicating in the same manner
05/30/2000US6069250 Method and compositions for the synthesis of dioxolane nucleosides with β-configuration
05/30/2000US6069162 Indolyl and benzofuranyl carboxamides as inhibitors of nitric oxide production
05/30/2000US6069157 Parasiticidal compounds
05/30/2000US6069156 Indole derivatives as cGMP-PDE inhibitors
05/30/2000US6069148 Cycloalkano-pyridines
05/30/2000US6069114 Herbicides for selectively controlling broad-leaved weeds and grass weeds in crops of useful plants
05/30/2000CA1341007C Alkyl- and alkenylsulfonylureas which are substituted in the heterocycle, processes for their preparation, and their use as herbicides or plant growth regulators
05/25/2000WO2000029497A1 Crosslinking agent for carboxyl-containing polymers in heat-curable systems
05/25/2000WO2000029381A1 Fluorinated 3,4-dihydroquinoline derivatives used as nos inhibitors
05/25/2000WO2000029377A1 4-aroyl-piperidin-ccr-3 receptor antagonists iii
05/25/2000WO2000018763A3 2-(2,3-dihydrobenzofuran-5-yl)-4-aminomethylimidazoles: dopamine receptor subtype specific ligands
05/25/2000WO2000011951A3 Use of 5-amino-pyrazol-derivatives for combating micro-organisms
05/25/2000CA2350722A1 4-aroyl-piperidin-ccr-3 receptor antagonists iii
05/25/2000CA2350443A1 Fluorinated 3,4-dihydroquinoline derivatives used as nos inhibitors
05/24/2000EP1002797A1 4,5-DIHYDRO- 1H]-BENZ g]INDAZOLE-3-CARBOXYLIC ACID DERIVATIVES
05/24/2000EP1001946A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56?1ck TYROSINE KINASES
05/24/2000EP1001945A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56?lck TYROSINE KINASES
05/24/2000EP1001943A1 Polyhydroxyalkylpyrazine derivatives, preparation and medicines containing them
05/24/2000EP1001942A1 Polyhydroxybutylpyrazines, their preparation and medicines containing them
05/24/2000EP1001939A1 Heterocyclic substituted 4-benzoyl-pyrazole as herbicides
05/24/2000EP1001934A1 Indole compounds as cox-2 inhibitors
05/24/2000EP1001933A1 Caspases and apoptosis
05/24/2000EP1001930A2 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
05/24/2000EP1001774A1 Use of phospholamban inhibitors to increasing coronary flow
05/24/2000EP1001769A4 Soluble prodrugs of paclitaxel
05/24/2000EP1001769A1 Soluble prodrugs of paclitaxel
05/24/2000EP0797386B1 Fungicidal mixture
05/24/2000CN1254337A N-hydroxy 4-sulfonyl butyramide compounds
05/24/2000CN1254335A Nicotinamide derivatives
05/24/2000CN1254334A Novel terephthalamide derivatives
05/24/2000CN1253948A Substituted tricyclic compound
05/24/2000CN1052723C Bicyclic aromatic compounds as therapeutic agents, its preparing method and drug composition containing said compound
05/24/2000CN1052722C Dibenzooxapine or thiapine derivative, its preparing method and drug composition
05/23/2000US6066740 From thiourea intermediate; for treatment of respiratory disorders, ocular disorders, gastrointestinal disorders, nasal decongestion, hypertension, migraine, disorders associated with sympathetic nervous system activity, and substance abuse
05/23/2000US6066737 Process for the preparation of optically enriched 4-aryl-3-hydromethyl substituted piperidines to be used as intermediates in the synthesis of paroxetine
05/23/2000US6066657 For the treatment of disease states associated with proteins which mediate cellular activity, for example by inhibiting tumor necrosis factor or phosphodiesterase iv
05/23/2000US6066650 Inhibitors of microsomal triglyceride transfer protein and method
05/23/2000US6066642 For selectively blocking the a3 adenosine receptor of a mammal
05/23/2000US6066638 Fungicidal pyrimidinones
05/23/2000US6066636 Muscarinic antagonists
05/23/2000US6066632 Heterocyclic compounds
05/23/2000US6066631 Bradycardial agent
05/23/2000US6066596 Herbicidal synergistic composition, and method of controlling weeds